PROTAC EGFR degrader 7 - HY-147858
Nur noch %1 verfügbar
Catalog #
HY-147858
Ab
258,00 €
PROTAC EGFR degrader 7 (compound 13b) is a potent and selective CRBN-recruiting PROTAC EGFRL858R/T790M degrader, with a DC50 of 13.2 nM. PROTAC EGFR degrader 7 inhibits NCI–H1975 cells proliferation, with an IC50 of 46.82 nM. PROTAC EGFR degrader 7 significantly induces apoptosis and G2/M phase arrest in NCI–H1975 cell. PROTAC EGFR degrader 7 shows antitumor activity, and can be used for non-small cell lung cancer (NSCLC) research[1]. PROTAC EGFR degrader 7 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-147858/PROTAC-EGFR-degrader-7-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-Kinase/protease |
| Storage | -20°C (Powder, sealed storage, away from moisture and light) |
| MWT | 836.94 |
| Solubility | DMSO : 120 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Apoptosis;EGFR;PROTACs |
| Application: | Cancer-Kinase/protease |
|---|